Court Sides With Teva

A U. S. District Court sided with Teva Pharmaceutical Industries Ltd. (TEVA) by sending the company's application for exclusive rights to sell a generic version of the anti-cholesterol drug Zocor back to the Food and Drug Administration. The stock price climbed $1.61 to close at $42.11.